VR Adviser, LLC Q1 2021 Filing
Filed May 14, 2021
Portfolio Value
$921.8B
Holdings
28
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILINSTIL BIO INC | 6,865,076 | $172.2B | 18.68% | |
| 2 | —CONSTELLATION PHARMACEUTICAL | 4,016,873 | $94.0B | 10.19% | |
| 3 | ACRSACLARIS THERAPEUTICS INC | 3,720,582 | $93.8B | 10.17% | |
| 4 | OLMAOLEMA PHARMACEUTICALS INC | 1,536,193 | $51.0B | 5.53% | |
| 5 | ALTALTIMMUNE INC | 3,500,000 | $49.5B | 5.37% | |
| 6 | CGEMCULLINAN MANAGEMENT INC | 1,176,145 | $49.0B | 5.32% | |
| 7 | —KINNATE BIOPHARMA INC | 1,473,014 | $45.9B | 4.98% | |
| 8 | TREURTRILLIUM THERAPEUTICS INC | 4,040,000 | $43.4B | 4.71% | |
| 9 | MRNS*MARINUS PHARMACEUTICALS INC | 2,641,809 | $40.9B | 4.44% | |
| 10 | VTGNUSDVISTAGEN THERAPEUTICS INC | 16,302,596 | $34.7B | 3.77% | |
| 11 | —ATHIRA PHARMA INC | 1,691,623 | $31.1B | 3.38% | |
| 12 | RLMDRELMADA THERAPEUTICS INC | 853,206 | $30.0B | 3.26% | |
| 13 | TCE2CELLDEX THERAPEUTICS INC | 1,240,610 | $25.6B | 2.77% | |
| 14 | PHVSPHARVARIS BV | 902,882 | $25.3B | 2.75% | |
| 15 | KROSKEROS THERAPEUTICS INC | 372,306 | $22.9B | 2.49% | |
| 16 | EPIEURESSA PHARMA INC | 625,754 | $18.2B | 1.97% | |
| 17 | KURAKURA ONCOLOGY INC | 575,000 | $16.3B | 1.76% | |
| 18 | SNDXSYNDAX PHARMACEUTICALS INC | 591,782 | $13.2B | 1.44% | |
| 19 | TORCEURADICET BIO INC | 1,000,000 | $13.1B | 1.42% | |
| 20 | —APTOSE BIOSCIENCES INC | 1,605,400 | $9.6B | 1.04% | |
| 21 | COGTCOGENT BIOSCIENCES INC | 1,088,817 | $9.6B | 1.04% | |
| 22 | ALGSALIGOS THERAPEUTICS INC | 408,377 | $9.3B | 1.01% | |
| 23 | EYPTEYEPOINT PHARMACEUTICALS INC | 700,000 | $7.1B | 0.77% | |
| 24 | —BCTG ACQUISITION CORP | 500,000 | $5.6B | 0.60% | |
| 25 | —METACRINE INC | 680,000 | $4.2B | 0.46% | |
| 26 | SPRYSILVERBACK THERAPEUTICS INC | 85,000 | $3.7B | 0.40% | |
| 27 | TSHATAYSHA GENE THERAPIES INC | 120,649 | $2.4B | 0.27% | |
| 28 | VRDNVIRIDIAN THERAPEUTICS INC | 19,495 | $326.0M | 0.04% |